Evidence map›Paper›PMID 41194529›Full record

ReviewThe FEBS journal2026

Multifaceted multivalency with a hub protein.

Douglas R Walker, Elisar J Barbar

Abstract readReview
In one paragraph

Review in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Douglas R WalkerDepartment of Biochemistry & Biophysics, Oregon State University, Corvallis, USA.
Elisar J BarbarDepartment of Biochemistry & Biophysics, Oregon State University, Corvallis, USA.ORCID 0000-0003-4892-5259

Funding

Multiscale characterization of a unique class of duplex, multivalent IDP systems-- Administrative Supplement to Support Undergraduate Summer Research ExperiencesR01GM141733 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARBAR, ELISAR J, ZUCKERMAN, DANIEL M · 2021 to 2024
$1.9M
NIGMS NIH HHS R01 GM141733NIGMS NIH HHS R01GM141733 t
6 · The paper itself

Abstract

Recent investigations into the interaction between LC8 and GKAP significantly contribute to our understanding of LC8 multivalency. This comprehensive approach addresses four features we find vital for elucidating the mechanisms governing polybivalent complexation behavior: registration control, binding motifs, linker lengths, and flexibility. By deepening our understanding of these characteristics, we move closer to predicting critical aspects of LC8-partner interactions, including whether partners assemble homogeneously or heterogeneously, the degree of flexibility between adjacent binding sites, the strength of binding, and, importantly, the functional consequences of these interactions solely based on the sequence of LC8 binding partners.

Indexed as

Binding SitesHumansModels, MolecularProtein Bindingcomplex regulationhub proteinintrinsically disordered proteinslinker lengthmultivalency

Identifiers

PMID41194529
PMCPMC13102031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.